<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q (AMENDMENT NO. 1)*
(Mark One)
/x/ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934 For the quarterly period ended June 30, 1996.
or
/ / Transition report pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934 For the transition period from to .
Commission File Number: 0-28170
OACIS HEALTHCARE HOLDINGS CORP.
(Exact name of registrant as specified in its charter)
DELAWARE 68-0012790
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
100 DRAKE'S LANDING RD., SUITE 100
GREENBRAE, CA 94904
(Address of principal executive offices, including zip code)
(415) 925-0121
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes / / No /x/
At August 8, 1996, there were 10,005,628 shares or the Registrant's Common
Stock outstanding.
* Amended to include Exhibit 11.1 -- Computation of Pro Forma Net Loss
Per Share.
<PAGE> 2
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
OACIS HEALTHCARE HOLDINGS CORP.
(Registrant)
Date August 14, 1996 /s/ Stephen F. Ghiglieri
------------------------- ---------------------------------
Stephen F. Ghiglieri
Vice President, Finance and Administration
Chief Financial Officer
(Principal Financial and Accounting Officer)
Date August 14, 1996 /s/ Jim McCord
------------------------- ---------------------------------
Jim McCord
Chairman and Chief Executive Officer
(Principal Executive Officer)
19
<PAGE> 3
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
EXHIBIT NUMBER DESCRIPTION PAGE
- -------------- ----------- ----
<S> <C> <C>
11.1 Computation of Pro Forma Net
Loss Per Share 21
</TABLE>
<PAGE> 1
EXHIBIT 11.1
CALCULATION OF PRO FORMA NET LOSS PER SHARE
<TABLE>
<CAPTION>
THREE MONTHS ENDED SIX MONTHS ENDED
JUNE 30, JUNE 30,
1995 1996 1995 1996
----------- ----------- ----------- -----------
<S> <C> <C> <C> <C>
Weighted Average Common and Common
Equivalent Shares:
Series A Preferred Stock 1,919,307 1,075,656 1,915,317 1,497,481
Series B Preferred Stock 2,946,726 1,745,448 2,875,252 2,429,937
Common Stock 1,745,667 5,373,682 1,741,304 3,559,674
Common Stock Options 883,710 495,265 883,710 689,488
Warrants 4,133 2,316 4,133 3,225
----------- ----------- ----------- -----------
7,499,543 8,692,367 7,419,716 8,179,805
=========== =========== =========== ===========
Net Loss ($2,160,000) ($1,989,000) ($4,267,000) ($4,839,000)
=========== =========== =========== ===========
Pro Forma net loss per common and
common equivalent share ($0.29) ($0.23) ($0.58) ($0.59)
=========== =========== =========== ===========
</TABLE>
